SB-656933

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-656933, covering 2018-03-14 to 2018-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis [Phase 2]